Rxivist logo

Rxivist combines preprints from bioRxiv with data from Twitter to help you find the papers being discussed in your field. Currently indexing 57,910 bioRxiv papers from 266,458 authors.

Precision Genome Editing Using Bacteriophage-derived Peptides

By Yanru Cui, Shaojie Wang, Jun Chen, Jie Li, Wenzhang Chen, Shuyue Wang, Bing Meng, Wei Zhu, Zhuhong Zhang, Bei Yang, Biao Jiang, Guang Yang, Peixiang Ma, Jia Liu

Posted 20 May 2019
bioRxiv DOI: 10.1101/642538

Protein and small molecule-based CRISPR inhibitors have been developed as selective off-switches to modulate CRISPR-Cas activity. These anti-CRISPR agents have important therapeutic implications because of their capability to improve the specificity of CRISPR-Cas in human cells. In this study, we reported the discovery of Cas9-inactivating peptides from inoviridae bacteriophages. These peptides, derived from the periplasmic domain of phage major coat protein G8P (G8PPD), can inhibit the in vitro cleavage activity of purified Streptococcus pyogenes Cas9 (SpyCas9) proteins in an allosteric manner. Ectopic expression of full-length G8P (G8PFL) or G8PPD in human cells can inactivate the genome-editing activity of SpyCas9 with minimum alterations of the mutation patterns. Most importantly, timed delivery of G8PPD can reduce the off-target activity of co-transfected SpyCas9 without compromising its on-target activity. Therefore, the G8Ps discovered in the current study represent the first anti-CRISPR peptides that can improve the specificity of constitutively expressed SpyCas9, implying the potential applications of G8Ps for precision genome editing.

Download data

  • Downloaded 278 times
  • Download rankings, all-time:
    • Site-wide: 32,106 out of 57,910
    • In genomics: 3,034 out of 4,058
  • Year to date:
    • Site-wide: 9,582 out of 57,910
  • Since beginning of last month:
    • Site-wide: 11,291 out of 57,910

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News